FDA-Device2024-03-27Class II

DCA Systems HbA1c Reagent Kit

Siemens Healthcare Diagnostics, Inc.
Hazard

The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.

Sold states
Worldwide distribution - US Nationwide and the country of Taiwan.
Affected count
74,211 Kits (Expanded 2/28/24: additional 72,892 kits)
Manufactured in
511 Benedict Ave, Tarrytown, NY, United States
Products
DCA Systems HbA1c Reagent Kit

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1304-2024

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief